N-Nitrosodimethylamine formation in metformin hydrochloride sustained-release tablets: Effects of metformin and hypromellose used in drug product formulation.

[1]  Michal Douša,et al.  N-Nitrosation in the absence of nitrosating agents in pharmaceuticals? , 2022, Journal of Pharmaceutical and Biomedical Analysis.

[2]  R. Boetzel,et al.  A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products. , 2022, Journal of pharmaceutical sciences.

[3]  Tim Müller,et al.  Avoiding N-Nitrosodimethylamine Formation in Metformin Pharmaceuticals by Limiting Dimethylamine and Nitrite. , 2022, International journal of pharmaceutics.

[4]  K. K. Nanda,et al.  Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study. , 2021, Journal of pharmaceutical sciences.

[5]  A. ElMeshad,et al.  Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products , 2021, Expert opinion on drug safety.

[6]  P. Řezanka,et al.  Insight into the formation of N-nitrosodimethylamine in metformin products. , 2020, Journal of pharmaceutical and biomedical analysis.

[7]  A. Teasdale,et al.  Potential for the Formation of N-Nitrosamines during the Manufacture of Active Pharmaceutical Ingredients: An Assessment of the Risk Posed by Trace Nitrite in Water , 2020 .

[8]  A. Gumieniczek,et al.  Determination of Chemical Stability of Two Oral Antidiabetics, Metformin and Repaglinide in the Solid State and Solutions Using LC-UV, LC-MS, and FT-IR Methods , 2019, Molecules.

[9]  S. Marshall.  60 years of metformin use: a glance at the past and a look to the future , 2017, Diabetologia.

[10]  N. Tajima,et al.  Long-term treatment study of global standard dose metformin in Japanese patients with type 2 diabetes mellitus , 2017, Diabetology International.

[11]  Lihong Fan,et al.  Preparation and characterization of aminoethyl hydroxypropyl methyl cellulose modified with nisin. , 2016, International journal of biological macromolecules.

[12]  I. Petersen,et al.  Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study , 2016, BMJ Open.

[13]  S. Lemieux,et al.  Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta‐analysis , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[14]  S. Badawy,et al.  Impact of Excipient Interactions on Solid Dosage Form Stability , 2012, Pharmaceutical Research.

[15]  A. Narang,et al.  Impact of Excipient Interactions on Drug Bioavailability from Solid Dosage Forms , 2012, Pharmaceutical Research.

[16]  Ajit S. Narang,et al.  Reactive Impurities in Excipients: Profiling, Identification and Mitigation of Drug–Excipient Incompatibility , 2011, AAPS PharmSciTech.

[17]  Hui Xu,et al.  Evaluation of hydroperoxides in common pharmaceutical excipients. , 2007, Journal of pharmaceutical sciences.

[18]  Takashige Nakamura,et al.  A simple assay for lipid hydroperoxides based on triphenylphosphine oxidation and high-performance liquid chromatography , 1991, Lipids.

[19]  P. Gao,et al.  Liquid chromatographic determination of residual hydrogen peroxide in pharmaceutical excipients using platinum and wired enzyme electrodes. , 2003, Journal of pharmaceutical and biomedical analysis.

[20]  H. Newmark,et al.  Antioxidants as Blocking Agents Against Nitrosamine Formation , 1980 .